{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:26:44Z","timestamp":1791397604259,"version":"4.3.3"},"reference-count":162,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.modpat.2024.100466","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T12:15:23Z","timestamp":1709813723000},"page":"100466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Fifth Edition of the World Health Organization Classification of Tumors of the Hematopoietic and Lymphoid Tissues: Acute Lymphoblastic Leukemias, Mixed-Phenotype Acute Leukemias, Myeloid\/Lymphoid Neoplasms With Eosinophilia, Dendritic\/Histiocytic Neoplasms, and Genetic Tumor Syndromes"],"prefix":"10.1016","volume":"37","author":[{"given":"John K.","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanam","family":"Loghavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kojo S.","family":"Elenitoba-Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kikkeri N.","family":"Naresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6173-6500","authenticated-orcid":false,"given":"Magdalena","family":"Czader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.modpat.2024.100466_bib2","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.modpat.2024.100466_bib3","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.modpat.2024.100466_bib4","doi-asserted-by":"crossref","first-page":"e352","DOI":"10.3324\/haematol.2018.214353","article-title":"CD371 cell surface expression: a unique feature of DUX4-rearranged acute lymphoblastic leukemia","volume":"104","author":"Schinnerl","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.modpat.2024.100466_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11790","article-title":"Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia","volume":"7","author":"Lilljebjorn","year":"2016","journal-title":"Nat Commun"},{"issue":"50","key":"10.1016\/j.modpat.2024.100466_bib6","doi-asserted-by":"crossref","first-page":"E11711","DOI":"10.1073\/pnas.1814397115","article-title":"Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases","volume":"115","author":"Li","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.modpat.2024.100466_bib7","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41588-018-0315-5","article-title":"PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia","volume":"51","author":"Gu","year":"2019","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.modpat.2024.100466_bib8","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/leu.2013.379","article-title":"High hyperdiploidy among adolescents and adults with acute lymphoblastic leukaemia (ALL): cytogenetic features, clinical characteristics and outcome","volume":"28","author":"Chilton","year":"2014","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.modpat.2024.100466_bib9","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1182\/blood-2003-04-1128","article-title":"Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia","volume":"102","author":"Moorman","year":"2003","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.modpat.2024.100466_bib10","doi-asserted-by":"crossref","first-page":"e828","DOI":"10.1016\/S2352-3026(21)00304-5","article-title":"Defining low-risk high hyperdiploidy in patients with paediatric acute lymphoblastic leukaemia: a retrospective analysis of data from the UKALL97\/99 and UKALL2003 clinical trials","volume":"8","author":"Enshaei","year":"2021","journal-title":"Lancet Haematol"},{"issue":"5","key":"10.1016\/j.modpat.2024.100466_bib11","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.hoc.2009.07.001","article-title":"Cytogenetics and molecular genetics of acute lymphoblastic leukemia","volume":"23","author":"Mr\u00f3zek","year":"2009","journal-title":"Hematol Oncol Clin North Am"},{"issue":"11","key":"10.1016\/j.modpat.2024.100466_bib12","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1038\/leu.2009.135","article-title":"PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study","volume":"23","author":"Familiades","year":"2009","journal-title":"Leukemia"},{"issue":"20","key":"10.1016\/j.modpat.2024.100466_bib13","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1182\/bloodadvances.2019001307","article-title":"Landscape of driver mutations and their clinical impacts in pediatric B-cell precursor acute lymphoblastic leukemia","volume":"4","author":"Ueno","year":"2020","journal-title":"Blood Adv. 27"},{"issue":"11","key":"10.1016\/j.modpat.2024.100466_bib14","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood.2020010144","article-title":"Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL","volume":"138","author":"Paietta","year":"2021","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.modpat.2024.100466_bib15","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1158\/2643-3230.BCD-20-0229","article-title":"Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy","volume":"2","author":"Jeha","year":"2021","journal-title":"Blood Cancer Discov"},{"issue":"8","key":"10.1016\/j.modpat.2024.100466_bib16","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.3324\/haematol.2020.250423","article-title":"DUX4r, ZNF384r and PAX5-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switch","volume":"106","author":"Novakova","year":"2021","journal-title":"Haematologica"},{"issue":"23","key":"10.1016\/j.modpat.2024.100466_bib17","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1182\/bloodadvances.2021004895","article-title":"Distinct clinical characteristics of DUX4- and PAX5-altered childhood B-lymphoblastic leukemia","volume":"5","author":"Li","year":"2021","journal-title":"Blood Adv"},{"issue":"21","key":"10.1016\/j.modpat.2024.100466_bib18","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood-2018-03-842088","article-title":"IG-MYC (+) neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas","volume":"132","author":"Wagener","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.modpat.2024.100466_bib19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3389\/fonc.2020.00273","article-title":"The physiopathology of T- cell acute lymphoblastic leukemia: focus on molecular aspects","volume":"10","author":"Fattizzo","year":"2020","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100466_bib20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cellsig.2013.09.021","article-title":"New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of gamma-secretase inhibitor resistant T-cell acute lymphoblastic leukemia","volume":"26","author":"Hales","year":"2014","journal-title":"Cell Signal"},{"issue":"2","key":"10.1016\/j.modpat.2024.100466_bib21","doi-asserted-by":"crossref","first-page":"808","DOI":"10.3390\/ijms22020808","article-title":"Comprehensive overview of gene rearrangements in childhood T-cell acute lymphoblastic leukaemia","volume":"22","author":"Mroczek","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.modpat.2024.100466_bib22","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fonc.2017.00218","article-title":"Leukemia-initiating cells in T-cell acute lymphoblastic leukemia","volume":"7","author":"Tan","year":"2017","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100466_bib23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1158\/2643-3230.BCD-20-0093","article-title":"T-cell acute lymphoblastic leukemia: a roadmap to targeted therapies","volume":"2","author":"Cordo","year":"2021","journal-title":"Blood Cancer Discov"},{"issue":"7380","key":"10.1016\/j.modpat.2024.100466_bib24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature10725","article-title":"The genetic basis of early T-cell precursor acute lymphoblastic leukaemia","volume":"481","author":"Zhang","year":"2012","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.modpat.2024.100466_bib25","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ccr.2011.02.008","article-title":"Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia","volume":"19","author":"Homminga","year":"2011","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.modpat.2024.100466_bib26","first-page":"773","article-title":"14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia","volume":"138","author":"Di Giacomo","year":"2021","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.modpat.2024.100466_bib27","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/bjh.17681","article-title":"B-cell lymphoma\/leukaemia 11B (BCL11B) expression status helps distinguish early T-cell precursor acute lymphoblastic leukaemia\/lymphoma (ETP-ALL\/LBL) from other subtypes of T-cell ALL\/LBL","volume":"194","author":"Fang","year":"2021","journal-title":"Br J Haematol"},{"issue":"13","key":"10.1016\/j.modpat.2024.100466_bib28","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1084\/jem.20090934","article-title":"GATA-3 is required for early T lineage progenitor development","volume":"206","author":"Hosoya","year":"2009","journal-title":"J\u00a0Exp Med"},{"issue":"1","key":"10.1016\/j.modpat.2024.100466_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053190","article-title":"FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitors","volume":"8","author":"Neumann","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.modpat.2024.100466_bib30","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ccell.2018.01.006","article-title":"Ezh2 and Runx1 mutations collaborate to initiate lympho-myeloid leukemia in early thymic progenitors","volume":"33","author":"Booth","year":"2018","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.modpat.2024.100466_bib31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","article-title":"Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia","volume":"10","author":"Coustan-Smith","year":"2009","journal-title":"Lancet Oncol"},{"issue":"15","key":"10.1016\/j.modpat.2024.100466_bib32","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1182\/blood-2015-08-661702","article-title":"Early T-cell precursor acute lymphoblastic leukemia\/lymphoma (ETP-ALL\/LBL) in adolescents and adults: a high-risk subtype","volume":"127","author":"Jain","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.modpat.2024.100466_bib33","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3324\/haematol.2013.090233","article-title":"Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptors","volume":"99","author":"Zuurbier","year":"2014","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.modpat.2024.100466_bib34","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/sj.leu.2404302","article-title":"Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast","volume":"20","author":"Graux","year":"2006","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.modpat.2024.100466_bib35","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1309\/2QE3A6EKQ8UYDYRC","article-title":"Precursor T-cell acute lymphoblastic leukemia\/lymphoblastic lymphoma and acute biphenotypic leukemias","volume":"127","author":"Han","year":"2007","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"10.1016\/j.modpat.2024.100466_bib36","first-page":"1116","article-title":"Genetic insights in the pathogenesis of T-cell acute lymphoblastic leukemia","volume":"90","author":"De Keersmaecker","year":"2005","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.modpat.2024.100466_bib37","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.3324\/haematol.2020.247031","article-title":"Pediatric acute lymphoblastic leukemia","volume":"105","author":"Inaba","year":"2020","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.modpat.2024.100466_bib38","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1200\/JCO.2016.70.7836","article-title":"Genetic basis of acute lymphoblastic leukemia","volume":"35","author":"Iacobucci","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.modpat.2024.100466_bib39","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/ng.3909","article-title":"The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia","volume":"49","author":"Liu","year":"2017","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.modpat.2024.100466_bib40","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.beha.2010.08.002","article-title":"Genetic rearrangements in relation to immunophenotype and outcome in T-cell acute lymphoblastic leukaemia","volume":"23","author":"Meijerink","year":"2010","journal-title":"Best Pract Res Clin Haematol"},{"issue":"2","key":"10.1016\/j.modpat.2024.100466_bib41","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2141.2008.07314.x","article-title":"Molecular-genetic insights in paediatric T-cell acute lymphoblastic leukaemia","volume":"143","author":"Van Vlierberghe","year":"2008","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100466_bib42","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1535-6108(02)00018-1","article-title":"Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia","volume":"1","author":"Ferrando","year":"2002","journal-title":"Cancer Cell"},{"issue":"17","key":"10.1016\/j.modpat.2024.100466_bib43","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1182\/blood.2020005381","article-title":"Integrative genomic analysis of pediatric T-cell lymphoblastic lymphoma reveals candidates of clinical significance","volume":"137","author":"Khanam","year":"2021","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.modpat.2024.100466_bib44","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1182\/blood-2012-11-465138","article-title":"Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations","volume":"121","author":"Neumann","year":"2013","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.modpat.2024.100466_bib45","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1182\/blood-2016-11-749978","article-title":"Monitoring of childhood ALL using BCR-ABL1 genomic breakpoints identifies a subgroup with CML-like biology","volume":"129","author":"Hovorkova","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.modpat.2024.100466_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.586567","article-title":"Multi-lineage BCR-ABL expression in Philadelphia chromosome-positive acute lymphoblastic leukemia is associated with improved prognosis but no specific molecular features","volume":"10","author":"Nishiwaki","year":"2020","journal-title":"Front Oncol"},{"issue":"7727","key":"10.1016\/j.modpat.2024.100466_bib47","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41586-018-0436-0","article-title":"The genetic basis and cell of origin of mixed phenotype acute leukaemia","volume":"562","author":"Alexander","year":"2018","journal-title":"Nature"},{"issue":"21","key":"10.1016\/j.modpat.2024.100466_bib48","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1182\/bloodadvances.2021005318","article-title":"A\u00a0novel class of ZNF384 aberrations in acute leukemia","volume":"5","author":"Zaliova","year":"2021","journal-title":"Blood Adv"},{"issue":"11","key":"10.1016\/j.modpat.2024.100466_bib49","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1158\/2159-8290.CD-21-0145","article-title":"Enhancer hijacking drives oncogenic BCL11B expression in lineage-ambiguous stem cell leukemia","volume":"11","author":"Montefiori","year":"2021","journal-title":"Cancer Discov"},{"issue":"15","key":"10.1016\/j.modpat.2024.100466_bib50","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1182\/blood-2010-11-318873","article-title":"The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia","volume":"118","author":"Gutierrez","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.modpat.2024.100466_bib51","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/bjh.17210","article-title":"Standardised immunophenotypic analysis of myeloperoxidase in acute leukaemia","volume":"193","author":"Bras","year":"2021","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.modpat.2024.100466_bib52","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/bjh.12277","article-title":"Flow cytometry thresholds of myeloperoxidase detection to discriminate between acute lymphoblastic or myeloblastic leukaemia","volume":"161","author":"Guy","year":"2013","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.modpat.2024.100466_bib53","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/cyto.b.21072","article-title":"A\u00a0threshold of 10% for myeloperoxidase by flow cytometry is valid to classify acute leukemia of ambiguous and myeloid origin","volume":"84","author":"van den Ancker","year":"2013","journal-title":"Cytometry B Clin Cytom"},{"issue":"23","key":"10.1016\/j.modpat.2024.100466_bib54","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1182\/bloodadvances.2018023531","article-title":"PHF6 and DNMT3A mutations are enriched in distinct subgroups of mixed phenotype acute leukemia with T-lineage differentiation","volume":"2","author":"Xiao","year":"2018","journal-title":"Blood Adv"},{"issue":"11","key":"10.1016\/j.modpat.2024.100466_bib55","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3324\/haematol.2012.064485","article-title":"Clinical, immunophenotypic, cytogenetic, and molecular genetic features in 117 adult patients with mixed-phenotype acute leukemia defined by WHO-2008 classification","volume":"97","author":"Yan","year":"2012","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.modpat.2024.100466_bib56","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.exphem.2016.05.003","article-title":"Mixed-phenotype acute leukemia (MPAL) exhibits frequent mutations in DNMT3A and activated signaling genes","volume":"44","author":"Eckstein","year":"2016","journal-title":"Exp Hematol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100466_bib57","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1038\/s41467-018-04924-z","article-title":"Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes","volume":"9","author":"Takahashi","year":"2018","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.modpat.2024.100466_bib58","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/ajh.25256","article-title":"Genomic and clinical characterization of B\/T mixed phenotype acute leukemia reveals recurrent features and T-ALL like mutations","volume":"93","author":"Mi","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.modpat.2024.100466_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.726637","article-title":"Enrichment of double RUNX1 mutations in acute leukemias of ambiguous lineage","volume":"11","author":"Merati","year":"2021","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100466_bib60","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-03709-7","article-title":"The association of complex genetic background with the prognosis of acute leukemia with ambiguous lineage","volume":"11","author":"Huang","year":"2021","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.modpat.2024.100466_bib61","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1080\/10428194.2018.1441410","article-title":"Outcome of patients with acute undifferentiated leukemia after allogeneic hematopoietic stem cell transplantation","volume":"59","author":"Kurosawa","year":"2018","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"10.1016\/j.modpat.2024.100466_bib62","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/s41379-019-0263-3","article-title":"Clinical, immunophenotypic, and genomic findings of acute undifferentiated leukemia and comparison to acute myeloid leukemia with minimal differentiation: a study from the bone marrow pathology group","volume":"32","author":"Weinberg","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.modpat.2024.100466_bib63","article-title":"Acute myeloid leukemia with mixed phenotype is characterized by stemness transcriptomic signatures and limited lineage plasticity","author":"Galera","year":"2023","journal-title":"medRxiv"},{"issue":"20","key":"10.1016\/j.modpat.2024.100466_bib64","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1182\/blood-2015-08-665547","article-title":"Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy","volume":"127","author":"Gardner","year":"2016","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.modpat.2024.100466_bib65","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27265","article-title":"Myeloid lineage switch following chimeric antigen receptor T-cell therapy in a patient with TCF3-ZNF384 fusion-positive B-lymphoblastic leukemia","volume":"65","author":"Oberley","year":"2018","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"10.1016\/j.modpat.2024.100466_bib66","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/pbc.25953","article-title":"Lineage switch in MLL-rearranged infant leukemia following CD19-directed therapy","volume":"63","author":"Rayes","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"18","key":"10.1016\/j.modpat.2024.100466_bib67","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1182\/blood-2017-05-782888","article-title":"Hematopoietic stem cell involvement in BCR-ABL1-positive ALL as a potential mechanism of resistance to blinatumomab therapy","volume":"130","author":"Nagel","year":"2017","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.modpat.2024.100466_bib68","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa025217","article-title":"A\u00a0tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome","volume":"348","author":"Cools","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.modpat.2024.100466_bib69","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s00277-017-3067-x","article-title":"Imatinib in myeloid\/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRB in chronic or blast phase","volume":"96","author":"Jawhar","year":"2017","journal-title":"Ann Hematol"},{"issue":"2","key":"10.1016\/j.modpat.2024.100466_bib70","doi-asserted-by":"crossref","first-page":"e278","DOI":"10.1038\/bcj.2014.95","article-title":"Comprehensive genomic profiling identifies a novel TNKS2-PDGFRA fusion that defines a myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy","volume":"5","author":"Chalmers","year":"2015","journal-title":"Blood Cancer J"},{"issue":"2","key":"10.1016\/j.modpat.2024.100466_bib71","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/leu.2008.309","article-title":"Detection and molecular monitoring of FIP1L1-PDGFRA-positive disease by analysis of patient-specific genomic DNA fusion junctions","volume":"23","author":"Score","year":"2009","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.modpat.2024.100466_bib72","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ajh.20833","article-title":"Imatinib mesylate responsiveness in aggressive systemic mastocytosis: novel association with a platelet derived growth factor receptor beta mutation","volume":"82","author":"Dalal","year":"2007","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.modpat.2024.100466_bib73","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000046641","article-title":"Myeloproliferative disorders with translocations of chromosome 5q31-35: role of the platelet-derived growth factor receptor Beta","volume":"107","author":"Steer","year":"2002","journal-title":"Acta Haematol"},{"issue":"3","key":"10.1016\/j.modpat.2024.100466_bib74","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/00000478-199203000-00003","article-title":"T-cell lymphoblastic lymphoma with eosinophilia associated with subsequent myeloid malignancy","volume":"16","author":"Abruzzo","year":"1992","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2024.100466_bib75","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s41379-018-0165-9","article-title":"Hematopoietic neoplasms with 9p24\/JAK2 rearrangement: a multicenter study","volume":"32","author":"Tang","year":"2019","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.modpat.2024.100466_bib76","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1038\/s41379-021-00817-7","article-title":"Myeloid\/lymphoid neoplasms with FLT3 rearrangement","volume":"34","author":"Tang","year":"2021","journal-title":"Mod Pathol"},{"issue":"11","key":"10.1016\/j.modpat.2024.100466_bib77","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.exphem.2007.07.002","article-title":"A\u00a0constitutively active SPTBN1-FLT3 fusion in atypical chronic myeloid leukemia is sensitive to tyrosine kinase inhibitors and immunotherapy","volume":"35","author":"Grand","year":"2007","journal-title":"Exp Hematol"},{"issue":"6","key":"10.1016\/j.modpat.2024.100466_bib78","doi-asserted-by":"crossref","first-page":"a003079","DOI":"10.1101\/mcs.a003079","article-title":"Two myeloid leukemia cases with rare FLT3 fusions","volume":"4","author":"Zhang","year":"2018","journal-title":"Cold Spring Harb Mol Case Stud"},{"issue":"8","key":"10.1016\/j.modpat.2024.100466_bib79","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/jcp.2008.058073","article-title":"Systemic mastocytosis with associated myeloproliferative disease and precursor B lymphoblastic leukaemia with t(13;13)(q12;q22) involving FLT3","volume":"61","author":"Tzankov","year":"2008","journal-title":"J\u00a0Clin Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100466_bib80","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1755-8166-6-39","article-title":"Myeloproliferative neoplasm with ETV6-ABL1 fusion: a case report and literature review","volume":"6","author":"Gancheva","year":"2013","journal-title":"Mol Cytogenet"},{"issue":"9","key":"10.1016\/j.modpat.2024.100466_bib81","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3324\/haematol.2016.144345","article-title":"Characterization of leukemias with ETV6-ABL1 fusion","volume":"101","author":"Zaliova","year":"2016","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.modpat.2024.100466_bib82","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0165-4608(02)00609-X","article-title":"Chronic myelocytic leukemia with eosinophilia, t(9;12)(q34;p13), and ETV6-ABL gene rearrangement: case report and review of the literature","volume":"138","author":"Keung","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"issue":"2","key":"10.1016\/j.modpat.2024.100466_bib83","first-page":"614","article-title":"Myeloid\/lymphoid neoplasms with eosinophilia\/ basophilia and ETV6-ABL1 fusion: cell-of-origin and response to tyrosine kinase inhibition","volume":"106","author":"Yao","year":"2021","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.modpat.2024.100466_bib84","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/modpathol.3800707","article-title":"Chronic myelomonocytic leukemia: The role of bone marrow biopsy immunohistology","volume":"19","author":"Orazi","year":"2006","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2024.100466_bib85","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/modpathol.2015.145","article-title":"Neoplasms derived from plasmacytoid dendritic cells","volume":"29","author":"Facchetti","year":"2016","journal-title":"Mod Pathol"},{"issue":"10","key":"10.1016\/j.modpat.2024.100466_bib86","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1182\/blood.2020007897","article-title":"Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia","volume":"137","author":"Xiao","year":"2021","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.modpat.2024.100466_bib87","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.3324\/haematol.2020.253740","article-title":"Plasmacytoid dendritic cells proliferation associated with acute myeloid leukemia: phenotype profile and mutation landscape","volume":"106","author":"Zalmai","year":"2021","journal-title":"Haematologica"},{"issue":"17","key":"10.1016\/j.modpat.2024.100466_bib88","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.3390\/cancers14174132","article-title":"Genetics and epigenetics in neoplasms with plasmacytoid dendritic cells","volume":"14","author":"Renosi","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.modpat.2024.100466_bib89","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/s41375-022-01538-9","article-title":"Bone marrow clonal hematopoiesis is highly prevalent in blastic plasmacytoid dendritic cell neoplasm and frequently sharing a clonal origin in elderly patients","volume":"36","author":"Khanlari","year":"2022","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.modpat.2024.100466_bib90","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1182\/blood-2010-04-279083","article-title":"Recurrent BRAF mutations in Langerhans cell histiocytosis","volume":"116","author":"Badalian-Very","year":"2010","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.modpat.2024.100466_bib91","doi-asserted-by":"crossref","first-page":"a034892","DOI":"10.1101\/cshperspect.a034892","article-title":"MAP-kinase-driven hematopoietic neoplasms: a decade of progress in the molecular age","volume":"11","author":"Chakraborty","year":"2021","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"10.1016\/j.modpat.2024.100466_bib92","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41572-021-00307-9","article-title":"Histiocytic disorders","volume":"7","author":"McClain","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"10.1016\/j.modpat.2024.100466_bib93","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/modpathol.2016.235","article-title":"Langerhans cell histiocytosis associated with lymphoma: an incidental finding that is not associated with BRAF or MAP2K1 mutations","volume":"30","author":"Pina-Oviedo","year":"2017","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100466_bib94","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00428-023-03508-7","article-title":"OCT2 expression in histiocytoses","volume":"483","author":"Ungureanu","year":"2023","journal-title":"Virchows Arch"},{"issue":"1","key":"10.1016\/j.modpat.2024.100466_bib95","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.pas.0000147395.01229.06","article-title":"Juvenile xanthogranuloma in childhood and adolescence: a clinicopathologic study of 129 patients from the kiel pediatric tumor registry","volume":"29","author":"Janssen","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2024.100466_bib96","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/pde.14174","article-title":"Juvenile xanthogranulomas: examining single, multiple, and extracutaneous presentations","volume":"37","author":"So","year":"2020","journal-title":"Pediatr Dermatol"},{"issue":"13","key":"10.1016\/j.modpat.2024.100466_bib97","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/blood-2012-05-430140","article-title":"High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses","volume":"120","author":"Haroche","year":"2012","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.modpat.2024.100466_bib98","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1182\/blood.2019003507","article-title":"Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era","volume":"135","author":"Goyal","year":"2020","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.modpat.2024.100466_bib99","first-page":"19","article-title":"Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity","volume":"7","author":"Foucar","year":"1990","journal-title":"Semin Diagn Pathol"},{"issue":"10","key":"10.1016\/j.modpat.2024.100466_bib100","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/modpathol.2017.55","article-title":"Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease","volume":"30","author":"Garces","year":"2017","journal-title":"Mod Pathol"},{"issue":"26","key":"10.1016\/j.modpat.2024.100466_bib101","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1182\/blood-2018-03-839753","article-title":"Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease","volume":"131","author":"Abla","year":"2018","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.modpat.2024.100466_bib102","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41379-018-0168-6","article-title":"ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusion","volume":"32","author":"Chang","year":"2019","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2024.100466_bib103","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1182\/blood.2021013338","article-title":"ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition","volume":"139","author":"Kemps","year":"2022","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.modpat.2024.100466_bib104","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/s41379-018-0200-x","article-title":"Identification of diverse activating mutations of the RAS-MAPK pathway in histiocytic sarcoma","volume":"32","author":"Shanmugam","year":"2019","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.modpat.2024.100466_bib105","doi-asserted-by":"crossref","first-page":"e1263","DOI":"10.1002\/onco.13801","article-title":"Histiocytic and dendritic cell sarcomas of hematopoietic origin share targetable genomic alterations distinct from follicular dendritic cell sarcoma","volume":"26","author":"Massoth","year":"2021","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.modpat.2024.100466_bib106","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/gte.1998.2.293","article-title":"High frequency of a common Bloom syndrome Ashkenazi mutation among Jews of Polish origin","volume":"2","author":"Shahrabani-Gargir","year":"1998","journal-title":"Genet Test"},{"issue":"5218","key":"10.1016\/j.modpat.2024.100466_bib107","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1126\/science.7792600","article-title":"A\u00a0single ataxia telangiectasia gene with a product similar to PI-3 kinase","volume":"268","author":"Savitsky","year":"1995","journal-title":"Science"},{"issue":"5534","key":"10.1016\/j.modpat.2024.100466_bib108","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/258427a0","article-title":"Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity","volume":"258","author":"Taylor","year":"1975","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.modpat.2024.100466_bib109","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1182\/blood.V87.2.423.bloodjournal872423","article-title":"Leukemia and lymphoma in ataxia telangiectasia","volume":"87","author":"Taylor","year":"1996","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.modpat.2024.100466_bib110","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1200\/JCO.21.01495","article-title":"Cancer in children with fanconi anemia and ataxia-telangiectasia-a nationwide register-based cohort study in Germany","volume":"40","author":"Dutzmann","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.modpat.2024.100466_bib111","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1038\/sj.emboj.7601703","article-title":"BRCA2 is required for neurogenesis and suppression of medulloblastoma","volume":"26","author":"Frappart","year":"2007","journal-title":"Embo j"},{"issue":"1","key":"10.1016\/j.modpat.2024.100466_bib112","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000452082","article-title":"Bloom's syndrome: clinical spectrum, molecular pathogenesis, and cancer predisposition","volume":"8","author":"Cunniff","year":"2017","journal-title":"Mol Syndromol"},{"issue":"5","key":"10.1016\/j.modpat.2024.100466_bib113","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1128\/MCB.01402-06","article-title":"The Bloom's syndrome helicase is critical for development and function of the alphabeta T-cell lineage","volume":"27","author":"Babbe","year":"2007","journal-title":"Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100466_bib114","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4049\/jimmunol.182.1.347","article-title":"Genomic instability resulting from Blm deficiency compromises development, maintenance, and function of the B cell lineage","volume":"182","author":"Babbe","year":"2009","journal-title":"J\u00a0Immunol"},{"issue":"17","key":"10.1016\/j.modpat.2024.100466_bib115","doi-asserted-by":"crossref","first-page":"6713--6126","DOI":"10.1128\/MCB.00296-06","article-title":"Mutation of the murine Bloom's syndrome gene produces global genome destabilization","volume":"26","author":"Chester","year":"2006","journal-title":"Mol Cell Biol"},{"issue":"4","key":"10.1016\/j.modpat.2024.100466_bib116","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.bj.2021.06.004","article-title":"RASopathies: From germline mutations to somatic and multigenic diseases","volume":"44","author":"Riller","year":"2021","journal-title":"Biomed J"},{"issue":"7","key":"10.1016\/j.modpat.2024.100466_bib117","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.1038\/bcj.2015.52","article-title":"Peripheral blood cells from children with RASopathies show enhanced spontaneous colonies growth in\u00a0vitro and hyperactive RAS signaling","volume":"5","author":"Gaipa","year":"2015","journal-title":"Blood Cancer J"},{"issue":"10","key":"10.1016\/j.modpat.2024.100466_bib118","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/ng.2754","article-title":"A\u00a0recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia","volume":"45","author":"Shah","year":"2013","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.modpat.2024.100466_bib119","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ejmg.2015.12.008","article-title":"Preexisting conditions in pediatric ALL patients: spectrum, frequency and clinical impact","volume":"59","author":"Schutte","year":"2016","journal-title":"Eur J Med Genet"},{"issue":"5","key":"10.1016\/j.modpat.2024.100466_bib120","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.ccell.2018.03.021","article-title":"Germline genetic IKZF1 variation and predisposition to childhood acute lymphoblastic leukemia","volume":"33","author":"Churchman","year":"2018","journal-title":"Cancer Cell. 14"},{"issue":"5","key":"10.1016\/j.modpat.2024.100466_bib121","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/ng.3253","article-title":"Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia","volume":"47","author":"Noetzli","year":"2015","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.modpat.2024.100466_bib122","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng.3177","article-title":"Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy","volume":"47","author":"Zhang","year":"2015","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.modpat.2024.100466_bib123","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/s41375-021-01163-y","article-title":"Clinical and genetic characteristics of children with acute lymphoblastic leukemia and Li-Fraumeni syndrome","volume":"35","author":"Winter","year":"2021","journal-title":"Leukemia"},{"issue":"25","key":"10.1016\/j.modpat.2024.100466_bib124","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1182\/blood-2019-01-895698","article-title":"Familial predisposition to TP53\/complex karyotype MDS and leukemia in DNA repair-deficient xeroderma pigmentosum","volume":"133","author":"Sarasin","year":"2019","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.modpat.2024.100466_bib125","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.3324\/haematol.2019.223370","article-title":"Predisposition to hematologic malignancies in patients with xeroderma pigmentosum","volume":"105","author":"Oetjen","year":"2020","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.modpat.2024.100466_bib126","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/ng.3301","article-title":"The genomic landscape of high hyperdiploid childhood acute lymphoblastic leukemia","volume":"47","author":"Paulsson","year":"2015","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.modpat.2024.100466_bib127","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/gcc.20671","article-title":"High hyperdiploid childhood acute lymphoblastic leukemia","volume":"48","author":"Paulsson","year":"2009","journal-title":"Genes Chromosom Cancer"},{"issue":"3","key":"10.1016\/j.modpat.2024.100466_bib128","doi-asserted-by":"crossref","first-page":"a026286","DOI":"10.1101\/cshperspect.a026286","article-title":"TP53 Mutations in hypodiploid acute lymphoblastic leukemia","volume":"7","author":"Comeaux","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"11","key":"10.1016\/j.modpat.2024.100466_bib129","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1038\/sj.leu.2403140","article-title":"Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome","volume":"17","author":"Robinson","year":"2003","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.modpat.2024.100466_bib130","doi-asserted-by":"crossref","first-page":"2327--2230","DOI":"10.1182\/blood-2006-08-040436","article-title":"Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21)","volume":"109","author":"Moorman","year":"2007","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.modpat.2024.100466_bib131","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1182\/blood-2014-08-569228","article-title":"Blood Spotlight on iAMP21 acute lymphoblastic leukemia (ALL), a high-risk pediatric disease","volume":"125","author":"Harrison","year":"2015","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.modpat.2024.100466_bib132","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/ajcp\/79.3.387","article-title":"Lymphoblastic lymphoma with the phenotype of common acute lymphoblastic leukemia","volume":"79","author":"Borowitz","year":"1983","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.modpat.2024.100466_bib133","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1309\/Q5GV-3K00-WAC6-BBUB","article-title":"Precursor B-cell lymphoblastic lymphoma. A study of nine cases lacking blood and bone marrow involvement and review of the literature","volume":"115","author":"Maitra","year":"2001","journal-title":"Am J Clin Pathol"},{"issue":"27","key":"10.1016\/j.modpat.2024.100466_bib134","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1200\/JCO.2013.49.1308","article-title":"Intrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standard-risk children's oncology group studies: a report from the children's oncology group","volume":"31","author":"Heerema","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"27","key":"10.1016\/j.modpat.2024.100466_bib135","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1200\/JCO.2013.48.9377","article-title":"Risk-directed treatment intensification significantly reduces the risk of relapse among children and adolescents with acute lymphoblastic leukemia and intrachromosomal amplification of chromosome 21: a comparison of the MRC ALL97\/99 and UKALL2003 trials","volume":"31","author":"Moorman","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"17","key":"10.1016\/j.modpat.2024.100466_bib136","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1056\/NEJMoa2016272","article-title":"Dasatinib-blinatumomab for Ph-positive acute lymphoblastic leukemia in adults","volume":"383","author":"Foa","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"7191","key":"10.1016\/j.modpat.2024.100466_bib137","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature06866","article-title":"BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros","volume":"453","author":"Mullighan","year":"2008","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.modpat.2024.100466_bib138","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1182\/blood.2019001244","article-title":"Efficacy of tyrosine kinase inhibitors in Ph-like acute lymphoblastic leukemia harboring ABL-class rearrangements","volume":"134","author":"Tanasi","year":"2019","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.modpat.2024.100466_bib139","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/leu.2015.177","article-title":"Multiplexed targeted sequencing of recurrent fusion genes in acute leukaemia","volume":"30","author":"Ruminy","year":"2016","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.modpat.2024.100466_bib140","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3324\/haematol.2015.136366","article-title":"Adults with Philadelphia chromosome-like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosis","volume":"102","author":"Herold","year":"2017","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.modpat.2024.100466_bib141","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1182\/blood-2016-07-726588","article-title":"Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults","volume":"129","author":"Jain","year":"2017","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.modpat.2024.100466_bib142","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1200\/JCO.2016.69.0073","article-title":"High frequency and poor outcome of Philadelphia chromosome-like acute lymphoblastic leukemia in adults","volume":"35","author":"Roberts","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.modpat.2024.100466_bib143","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41408-020-0313-6","article-title":"NARASIMHA: novel assay based on targeted RNA sequencing to identify ChiMeric gene fusions in hematological malignancies","volume":"10","author":"Patkar","year":"2020","journal-title":"Blood Cancer J"},{"issue":"7","key":"10.1016\/j.modpat.2024.100466_bib144","first-page":"554","article-title":"Philadelphia chromosome-like acute lymphoblastic leukemia: progress in a new cancer subtype","volume":"15","author":"Wells","year":"2017","journal-title":"Clin Adv Hematol Oncol"},{"issue":"9","key":"10.1016\/j.modpat.2024.100466_bib145","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.3324\/haematol.2018.207019","article-title":"BCR-ABL1-like acute lymphoblastic leukemia in childhood and targeted therapy","volume":"105","author":"Cario","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.modpat.2024.100466_bib146","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fped.2017.00004","article-title":"MLL-rearranged leukemias-an update on science and clinical approaches","volume":"5","author":"Winters","year":"2017","journal-title":"Front Pediatr"},{"issue":"11","key":"10.1016\/j.modpat.2024.100466_bib147","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1038\/leu.2013.135","article-title":"The MLL recombinome of acute leukemias in 2013","volume":"27","author":"Meyer","year":"2013","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.modpat.2024.100466_bib148","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3324\/haematol.2009.011346","article-title":"Clinical features and prognostic implications of TCF3-PBX1 and ETV6-RUNX1 in adult acute lymphoblastic leukemia","volume":"95","author":"Burmeister","year":"2010","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.modpat.2024.100466_bib149","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1182\/blood.V88.11.4252.bloodjournal88114252","article-title":"TEL\/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia","volume":"88","author":"McLean","year":"1996","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.modpat.2024.100466_bib150","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/gcc.22464","article-title":"ETV6\/RUNX1-like acute lymphoblastic leukemia: A novel B-cell precursor leukemia subtype associated with the CD27\/CD44 immunophenotype","volume":"56","author":"Zaliova","year":"2017","journal-title":"Genes Chromosom Cancer"},{"issue":"3","key":"10.1016\/j.modpat.2024.100466_bib151","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1182\/blood.2020006164","article-title":"Molecular basis of ETV6-mediated predisposition to childhood acute lymphoblastic leukemia","volume":"137","author":"Nishii","year":"2021","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.modpat.2024.100466_bib152","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/sj.leu.2404496","article-title":"Hypercalcemia in childhood acute lymphoblastic leukemia: frequent implication of parathyroid hormone-related peptide and E2A-HLF from translocation 17;19","volume":"21","author":"Inukai","year":"2007","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.modpat.2024.100466_bib153","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/leu.2009.42","article-title":"Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)\/TCF3-PBX1","volume":"23","author":"Jeha","year":"2009","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.modpat.2024.100466_bib154","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/ng.3362","article-title":"Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options","volume":"47","author":"Fischer","year":"2015","journal-title":"Nat Genet"},{"issue":"11","key":"10.1016\/j.modpat.2024.100466_bib155","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1080\/10428194.2019.1602267","article-title":"The first case of elderly TCF3-HLF-positive B-cell acute lymphoblastic leukemia","volume":"60","author":"Takeda","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.modpat.2024.100466_bib156","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.3389\/fonc.2019.01374","article-title":"B-ALL with t(5;14)(q31;q32); IGH-IL3 rearrangement and eosinophilia: a comprehensive analysis of a peculiar IGH-rearranged B-ALL","volume":"9","author":"Fournier","year":"2019","journal-title":"Front Oncol"},{"issue":"5","key":"10.1016\/j.modpat.2024.100466_bib157","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/ng.3535","article-title":"Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults","volume":"48","author":"Yasuda","year":"2016","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.modpat.2024.100466_bib158","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.3324\/haematol.2018.204487","article-title":"ERG deletions in childhood acute lymphoblastic leukemia with DUX4 rearrangements are mostly polyclonal, prognostically relevant and their detection rate strongly depends on screening method sensitivity","volume":"104","author":"Zaliova","year":"2019","journal-title":"Haematologica"},{"issue":"28","key":"10.1016\/j.modpat.2024.100466_bib159","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1200\/JCO.2016.66.5547","article-title":"MEF2D-BCL9 fusion gene is associated with high-risk acute B-cell precursor lymphoblastic leukemia in adolescents","volume":"34","author":"Suzuki","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.modpat.2024.100466_bib160","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1101\/gr.209163.116","article-title":"Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP","volume":"27","author":"Qian","year":"2017","journal-title":"Genome Res"},{"issue":"1","key":"10.1016\/j.modpat.2024.100466_bib161","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3324\/haematol.2016.151035","article-title":"ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype","volume":"102","author":"Hirabayashi","year":"2017","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.modpat.2024.100466_bib162","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s41379-019-0206-z","article-title":"NUTM1-rearranged neoplasia: a multi-institution experience yields novel fusion partners and expands the histologic spectrum","volume":"32","author":"Stevens","year":"2019","journal-title":"Mod Pathol"},{"issue":"10","key":"10.1016\/j.modpat.2024.100466_bib163","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1038\/s41375-021-01333-y","article-title":"Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study","volume":"35","author":"Boer","year":"2021","journal-title":"Leukemia"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395224000462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395224000462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T06:21:34Z","timestamp":1746080494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395224000462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":162,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0893395224000462"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2024.100466","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fifth Edition of the World Health Organization Classification of Tumors of the Hematopoietic and Lymphoid Tissues: Acute Lymphoblastic Leukemias, Mixed-Phenotype Acute Leukemias, Myeloid\/Lymphoid Neoplasms With Eosinophilia, Dendritic\/Histiocytic Neoplasms, and Genetic Tumor Syndromes","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2024.100466","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 United States & Canadian Academy of Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100466"}}